Published on in Vol 12 (2023)
This is a member publication of University of Oxford (Jisc)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/46741, first published
.
![Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST) Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)](https://asset.jmir.pub/assets/92d8b1242a47755fa9a0240583b2f394.png 480w,https://asset.jmir.pub/assets/92d8b1242a47755fa9a0240583b2f394.png 960w,https://asset.jmir.pub/assets/92d8b1242a47755fa9a0240583b2f394.png 1920w,https://asset.jmir.pub/assets/92d8b1242a47755fa9a0240583b2f394.png 2500w)
Journals
- Celis-Preciado C, Leclerc S, Duval M, Cliche D, Larivée P, Lemaire-Paquette S, Lévesque S, Côté A, Lachapelle P, Couillard S. Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study. BMJ Open Respiratory Research 2023;10(1):e001932 View